Additive effects of a cholinesterase inhibitor and a histamine inverse agonist on scopolamine deficits in humans.
Cho W, Maruff P, Connell J, Gargano C, Calder N, Doran S, Fox-Bosetti S, Hassan A, Renger J, Herman G, Lines C, Verma A.
Cho W, et al. Among authors: lines c.
Psychopharmacology (Berl). 2011 Dec;218(3):513-24. doi: 10.1007/s00213-011-2344-y. Epub 2011 Jun 7.
Psychopharmacology (Berl). 2011.
PMID: 21644059
Clinical Trial.